Smell and Taste Loss Associated with COVID ‐19 Infection
The Laryngoscope · 2023
DOI: 10.1002/lary.30802 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2023. Verfasst von Margaret B Mitchell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Massachusetts Eye & Ear, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: COVID-19, Ageusia, Olfaction Disorders. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim of this study was to quantify the impact of COVID‐19 on olfactory and gustatory function in US adults.
Methods
From the 2021 Adult National Health Interview Survey, demographic and survey‐specific module data concerning COVID‐19 diagnoses, testing and disease severity, and data quantifying disturbances and eventual recovery of smell and taste were extracted. Sample weights were applied to obtain nationally representative statistics. The overall rate of COVID‐19 infection was determined, and those diagnosed with COVID‐19 were analyzed with respect to disease severity, smell and taste disturbance, and respective recoveries.
Results
In 2021, 35.8 million or 14% of the adult population (95% CI 13.5–14.7%; mean age, 43.9 years; 53.8% female) had been diagnosed with COVID‐19. Among those, 60.5% (58.6–62.5%) and 58.2% (56.2–60.1%) reported accompanying losses in smell or taste, respectively; there was a significant association between overall COVID‐19 symptom severity and smell ( p < 0.001) and taste disturbance ( p < 0.001). Following infection, 72.2% (69.9–74.3%), 24.1% (22.2–26.2%), and 3.7% (3.0–4.6%) of the patients experienced complete, partial, and no smell recovery, respectively. Recovery rates for gustatory function paralleled olfaction, with 76.8% (74.6–78.9%), 20.6% (18.7–22.7%), and 2.6 (1.9–3.4%) reporting complete, partial, and no recovery of taste, respectively. When sensory disturbance was present, severity of overall symptomatology was negatively associated with smell and taste recovery ( p < 0.001 for each).
Conclusion
The majority of adults infected with COVID‐19 in 2021 experienced olfactory or gustatory dysfunction with a non‐negligible population reporting incomplete or no near‐term sensory recovery. Our results are useful for providers counseling patients and suggest that interventions lessening overall COVID‐19 symptom burden may prevent prolonged sensory dysfunction. Level of Evidence 4 Laryngoscope , 133:2357–2361, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, Massachusetts Eye & Ear, Boston, Massachusetts, USA.
ORCID-Profile: Margaret B Mitchell, Alan D Workman, Vinay K Rathi, Neil Bhattacharyya
Zitieren
APA
Mitchell, M. B., Workman, A. D., Rathi, V. K., & Bhattacharyya, N. (2023). Smell and Taste Loss Associated with COVID ‐19 Infection. The Laryngoscope. https://doi.org/10.1002/lary.30802
Vancouver
Mitchell MB, Workman AD, Rathi VK, Bhattacharyya N. Smell and Taste Loss Associated with COVID ‐19 Infection. The Laryngoscope. 2023. doi:10.1002/lary.30802
BibTeX
@article{Mitchell2023,
author = {Mitchell, Margaret B and Workman, Alan D and Rathi, Vinay K and Bhattacharyya, Neil},
title = {Smell and Taste Loss Associated with COVID ‐19 Infection},
journal = {The Laryngoscope},
year = {2023},
doi = {10.1002/lary.30802}
}
EUVIMED